Two giants of commercial gene research, Celera Genomics of Rockville,
Maryland, and Geron of Menlo Park, California, signed a deal this week to work
towards growing brand new organs from a patient’s own cells. Geron has a unique
supply of human stem cells, which can theoretically grow into particular sorts
of tissue, while sequencing heavyweight Celera will identify genes which control
tissue formation in embryos. “Our work under this alliance will bring us one
step closer to realising the therapeutic potential of human stem cells,” says
Thomas Okarma, Geron’s president.
To continue reading, today with our introductory offers
Advertisement
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
PCOS postpones perimenopause and allows pregnancies at older ages
2
Red-light therapy does have health benefits but not the ones you think
3
Man destined for Alzheimer's may have been saved by accidental therapy
4
A lost ancient script reveals how writing as we know it really began
5
Where has the deadly hantavirus come from and how does it spread?
6
The greatest David Attenborough documentaries you really need to watch
7
Woman in cancer remission without treatment in highly unusual case
8
Hantavirus outbreak will not cause a covid-style pandemic, says WHO
9
Extinct relative of koalas discovered in Western Australia
10
The problem of cosmic inflation and how to solve it
